datetime,headline,summary,related,lang,source
2020-11-12 06:30:27-05:00,"New Revoluation in Oxidative Stress Assay Market 2020 Massive Growth & Scope by 2020-2027 Focusing Top Players : SolarReserve BioVision, Inc. ,Enzo Biochem ,Merck and Co., Inc & More.",Oxidative Stress Assay Market report is to provide accurate and strategic analysis of the Profile Projectors industry. The report closely examines each segment and its sub-segment futures before looking at the 360-degree view of the market mentioned above. Market forecasts,ENZ,en,OpenPR
2020-10-27 05:54:40-05:00,"Reversine Market Increased International Trade Opening New Opportunities by 2020-2025 | Merck, STEMCELL, Cayman Chemical, Creative Enzymes, Selleck Chemicals, Axon Medchem, Enzo Biochem",This report provides in-depth study on the current state of the Global Reversine Market 2020-2025. Key players in the Global Reversine Market have been identified through the secondary research and their market share has been determined through primary and secondary,ENZ,en,OpenPR
2020-10-16 05:19:41-05:00,"Global Oxidative Stress Analysis Market 2020 Future Estimations with Top Key Players - Abcam, Cell Biolabs, Qiagen NV, Enzo Biochem, Biovision","The most recent market research study titled Global Oxidative Stress Analysis Market 2020 by Company, Regions, Type and Application, Forecast to 2025 offers a concise study on the market to illustrate valuable insights related to significant market trends. The report spotlights",ENZ,en,OpenPR
2020-10-14 06:53:08-05:00,"The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts",Here's a roundup of top developments in … Full story available on Benzinga.com,ENZ,en,Benzinga
2020-04-23 12:22:51-05:00,Why Enzo Biochem Shares Are Rallying,"Enzo Biochem, Inc. (NYSE: ENZ ) shares were rallying Thursday following an update from the company on its comprehensive COVID-19 program. The New York-based biosciences and diagnostic company said its COVID-19 suite now includes molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on its ELISA platform … Full story available on Benzinga.com",ENZ,en,Benzinga
2020-04-23 04:16:00-05:00,Stock Alert: Enzo Biochem Shares Jump 28% In Early Trading,"Shares of Enzo Biochem Inc. (ENZ) are rising over 28% in pre-market today, after the company announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on Enzo's ELISA platform, and a promising proprietary drug candidate (SK1-I).",ENZ,en,RTT News
2020-03-30 16:56:10-05:00,SCOTUS turns away Enzo plea to revisit patent enablement,"The U.S. Supreme Court on Monday turned away an appeal by Enzo Biochem Inc of a ruling that invalidated some of its medical testing patents, rebuffing the company's arguments that the decision contradicted precedent and contravened the standard of proof for proving patent invalidity.",ENZ,en,Reuters
2020-03-19 06:37:15-05:00,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.",ENZ,en,Benzinga
2020-03-10 08:19:55-05:00,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.","ENZ,EOLS",en,Benzinga
2020-03-09 08:46:40-05:00,Enzo Developments to Spur Big Stock Rise,"Enzo Biochem, Inc. (NYSE:ENZ) rose sharply in Monday trading, after a wild end to last week Shares of Enzo jumped over 50% on Friday after the company’s fiscal second-quarter revenue edged up from $19.3 million in 2019 to $19.4 million in 2020. …",ENZ,en,Baystreet.ca
2020-03-06 15:48:25-05:00,4 Biotech Stocks Moving On COVID-19 Updates,"The COVID-19 outbreak has proved to be a catalyst for biotechs. Some issues that were wallowing in penny stock territory have posted stratospheric gains in the wake of efforts to develop diagnostic tests, treatments and vaccines to combat the new coronavirus. Here are four stocks that were moving in Friday's session on coronavirus-related news: Spherix Inc (NASDAQ: SPEX ) Spherix said it has executed an exclusive option agreement with the University of Maryland Baltimore for the technology covered by a patent entitled ""Methods of Treating Coronavirus Infection."" The invention was made with aid from the National Institute of Health. Under the option, Spherix has until the end of May 2020 to complete due diligence and execute a license agreement for commercial development. Enzo Biochem, Inc. (NYSE: ENZ ) The diagnostic company said its … Full story available on Benzinga.com",ENZ,en,Benzinga
2020-02-25 10:27:00-05:00,Shareholders Support the Election of Both HDF Nominees to Enzo Board of Directors,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today announced that, based on a preliminary vote count provided by its proxy solicitor, Enzo shareholders voted to elect HDF nominees, Fabian Blank and Peter Clemens, and Company nominee Rebecca Fischer, to the Board of Directors (the “Boa",ENZ,en,Business Wire
2020-02-25 08:28:09-05:00,"The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.","ENTA,ENZ",en,Benzinga
2020-02-19 17:16:00-05:00,ISS Recommends Shareholders Vote AGAINST Enzo Proposal to Increase Size of Board,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today announced that a leading proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has recommended that shareholders vote on the BLUE proxy card AGAINST Enzo’s proposal to amend its bylaws in order to increase the size of",ENZ,en,Business Wire
2020-02-13 08:05:12-05:00,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (NASDAQ: AGRX ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Aptose Biosciences Inc (NASDAQ: APTO ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Avrobio Inc (NASDAQ: AVRO ) Beam Therapeutics Inc (NASDAQ: BEAM ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fate Therapeutics Inc (NASDAQ: FATE ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) NeoGenomics, Inc. (NASDAQ: NEO ) Novartis AG (NYSE: NVS ) Ocular Therapeutix Inc (NASDAQ: OCUL ) PAVmed Inc (NASDAQ: PAVM ) Penumbra Inc (NYSE: PEN ) Prevail Therapeutics Inc (NASDAQ: PRVL )(reacted to the FDA according Orphan Drug Designation to its experimental gene therapy PR001 for treating Gaucher disease) PTC Therapeutics, Inc (NASDAQ: PTCT ) Repligen Corporation (NASDAQ: RGEN ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) West Pharmaceutical Services Inc.",ENZ,en,Benzinga
2020-02-12 09:18:32-05:00,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NASDAQ: XLRN ) Agile Therapeutics Inc (NASDAQ: AGRX )( announced securing of loan facility) Allergan plc (NYSE: AGN ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE ) Cytokinetics, Inc. (NASDAQ: CYTK ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Nevro Corp (NYSE: NVRO ) Novartis AG (NYSE: NVS )(announced priority review for its lung cancer drug) Pacira Biosciences Inc (NASDAQ: PCRX ) PAVmed Inc (NASDAQ: PAVM )(PAVmed's EsoGuard Esophageal DNA test was accorded Breakthrough Device designation) Penumbra Inc (NYSE: PEN ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Seattle Genetics, Inc. (NASDAQ: SGEN )(announced positive data readout for ADC in bladder cancer) Syneos Health Inc (NASDAQ: SYNH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 11) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Brickell Biotech Inc (NASDAQ: BBI ) Endologix, Inc. (NASDAQ: ELGX ) Enzo Biochem, Inc. (NYSE: ENZ )( received New York State approval for its gynecological …",ENZ,en,Benzinga
2020-02-11 07:23:06-05:00,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.","ENZ,EOLS",en,Benzinga
2020-01-30 08:57:00-05:00,"Global H. Pylori Diagnostics Market, 2020 - Abbott, Enzo Biochem, Leica Biosystems, SeraCare & Thermo Fisher - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""2020 Global H. Pylori Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies"" report has been added to ResearchAndMarkets.com's offering. The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of",ENZ,en,Business Wire
2020-01-30 06:09:00-05:00,"2020 Global Blastocystis Hominis Diagnostics Market - Abbott, Cepheid, Enzo Biochem, Leica Biosystems & Takara Bio - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""2020 Global Blastocystis Hominis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies"" report has been added to ResearchAndMarkets.com's offering. The report presents a detailed analysis of the diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on definition, epidemiology and etiology are reviewed. The report",ENZ,en,Business Wire
2020-01-29 10:51:00-05:00,Harbert Discovery Fund Comments on Enzo Biochem’s Entrenchment Maneuvers,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today issued the following statement commenting on Enzo’s January 28, 2020 press release announcing the postponement of its 2019 Annual Meeting of Shareholders (the “Annual Meeting”) to February 25, 2020 and proposing the potential expansio",ENZ,en,Business Wire
2020-01-29 06:18:00-05:00,"Encephalitis Diagnostics Market, 2020 - Becton Dickinson, Enzo Biochem, Leica Biosystems &Takara Bio - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""2020 Encephalitis Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - US, Europe, Japan - Hospitals, Commercial and Public Health Labs, POC Locations"" report has been added to ResearchAndMarkets.com's offering. The report presents a detailed analysis of the Encephalitis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etio",ENZ,en,Business Wire
2020-01-28 10:58:00-05:00,"Global E. Coli Diagnostics Market, 2020 - Abbott, Enzo Biochem, Leica Biosystems, Roche & SeraCare - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""2020 Global E. Coli Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies"" report has been added to ResearchAndMarkets.com's offering. The report contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the E. Coli definition, epidemiolog",ENZ,en,Business Wire
2020-01-21 14:36:00-05:00,All Three Proxy Advisory Firms Recommend Shareholders Vote FOR Change to the Board of Enzo Biochem on the Blue Card,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today announced that Egan-Jones Proxy Services (“Egan-Jones”) has recommended shareholders vote for both HDF nominees on the Blue proxy card. All three leading proxy advisors – Egan-Jones, Glass, Lewis and Co. (“Glass Lewis”) and Institutio",ENZ,en,Business Wire
2020-01-16 13:03:00-05:00,Glass Lewis Recommends Shareholders Vote For the Election of Both Harbert Discovery Fund Nominees to Enzo Biochem’s Board,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today announced that a leading proxy advisory firm, Glass, Lewis & Co. (“Glass Lewis”), has recommended that shareholders vote on the BLUE proxy card in support of HDF’s two highly-qualified independent nominees, Fabian Blank and Peter",ENZ,en,Business Wire
2020-01-10 07:13:12-05:00,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 9) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc (NYSE: AGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) ( announced positive midstage results for its gene therapy to treat inherited eye disorder) Applied Therapeutics Inc (NASDAQ: APLT ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) DBV TECHNOLOGIE/S ADR (NASDAQ: DBVT ) (reported positive results for a late-stage study of its peanut allergy patch) DexCom, Inc. (NASDAQ: DXCM ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Inspire Medical Systems Inc (NYSE: INSP ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Masimo Corporation (NASDAQ: MASI ) Medtronic PLC (NYSE: MDT )(announced the acquisition of Stimgenics) Molecular Templates Inc (NASDAQ: MTEM ) Morphosys Ag (NASDAQ: MOR ) NuVasive, Inc.",ENZ,en,Benzinga
2020-01-08 09:00:00-05:00,Harbert Discovery Fund Releases Detailed Investor Presentation Highlighting Case for Change at Enzo Biochem,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owner of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today released a detailed investor presentation on Enzo. The presentation outlines the Company’s history of value destruction, persistent underperformance, and corporate governance issues and details HDF’s Nominees’ strategic plan to realize",ENZ,en,Business Wire
2019-12-30 09:00:00-05:00,Harbert Discovery Fund Sends Letter to Fellow Enzo Biochem Shareholders,"BIRMINGHAM, Ala.--(BUSINESS WIRE)--Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owner of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), sent a detailed letter to shareholders today highlighting HDF’s case for change at Enzo, including the opportunity for shareholders to elect two highly-qualified, fresh voices – Fabian Blank and Peter Clemens – to the Company’s Board of Dire",ENZ,en,Business Wire
2019-12-14 19:01:58-05:00,"Is Enzo Biochem, Inc. (ENZ) Going To Burn These Hedge Funds ?","Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The last 12 months is one of those periods",ENZ,en,Yahoo Finance
2019-11-18 08:00:00-05:00,Global Esoteric Testing Market 2019-2023 | Evolving Opportunities with Enzo Biochem Inc. and Eurofins Scientific | Technavio,LONDON--(BUSINESS WIRE)-- #Biotechnology--Global esoteric testing market is poised to grow by USD 14.53 billion during 2019-2023 at a CAGR of almost 12% during the forecast period.,ENZ,en,Business Wire
2019-04-22 11:16:12-05:00,Enzo settles patent dispute with Hologic and Grifols,Enzo Biochem ([[ENZ]] +1.4%) subsidiary Enzo Life Sciences has settled its patent infringement litigation against Hologic ([[HOLX]] -1.4%) and Grifols' ([[,ENZ,en,Seeking Alpha
